Data as of Dec 06
| -0.14 / -0.43%|
The 8 analysts offering 12-month price forecasts for WuXi Pharmatech (Cayman) Inc have a median target of 34.50, with a high estimate of 38.00 and a low estimate of 28.00. The median estimate represents a +5.83% increase from the last price of 32.60.
The current consensus among 10 polled investment analysts is to Buy stock in WuXi Pharmatech (Cayman) Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.